Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?

OBJECTIVES: To investigate the combined effects of rosiglitazone and pravastatin on renal functions in early streptozotocin induced diabetic nephropathy (DN). METHODS: This study was carried out at King Khalid University Hospital Animal House, Riyadh, Saudi Arabia from August 2013 to February 2014....

Descripción completa

Detalles Bibliográficos
Autor principal: Gad, Hayam I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362144/
https://www.ncbi.nlm.nih.gov/pubmed/25399210

Ejemplares similares

Ejemplares similares